Ethnic Disparity in Intracranial Hemorrhage Among Anticoagulated Patients With Atrial Fibrillation. An Answer in Search of a Question?**Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 4, 2007, Pages 316-318

  Falk, Rodney H ^a  

^a HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

ANTICOAGULATION; BRAIN HEMORRHAGE; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; STROKE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CALIFORNIA; CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 34447311087     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.04.043     Document Type: Editorial

References (23)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
2. Aguilar M.I., Hart R.G., Kase C.S., et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 82 (2007) 82-92
3. Ferro J.M. Update on intracerebral haemorrhage. J Neurol 253 (2006) 985-999
4. Flaherty M.L., Haverbusch M., Sekar P., et al. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 5 (2006) 197-201
5. Flaherty M.L., Kissela B., Woo D., et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68 (2007) 116-121
6. Labovitz D.L., Halim A., Boden-Albala B., Hauser W.A., and Sacco R.L. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 65 (2005) 518-522
7. Pautas E., Gouin-Thibault I., Debray M., Gaussem P., and Siguret V. Haemorrhagic complications of vitamin K antagonists in the elderly: risk factors and management. Drugs Aging 23 (2006) 13-25
8. Shen A.Y.-J., Yao J.F., Brar S.S., Jorgensen M.B., and Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50 (2007) 309-315
9. Lindh J.D., Lundgren S., Holm L., Alfredsson L., and Rane A. Several-fold increase in risk of overanticoagulation by CYP2C9 mutations. Clin Pharmacol Ther 78 (2005) 540-550
10. Rieder M.J., Reiner A.P., Gage B.F., et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352 (2005) 2285-2293
11. Lee S.C., Ng S.S., Oldenburg J., et al. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clin Pharmacol Ther 79 (2006) 197-205
12. Li T., Lange L.A., Li X., et al. Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation. J Med Genet 43 (2006) 740-744
13. Moridani M., Fu L., Selby R., et al. Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort. Clin Biochem 39 (2006) 606-612
14. Schalekamp T., Brasse B.P., Roijers J.F., et al. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation. Clin Pharmacol Ther 80 (2006) 13-22
15. Song Y.M., Sung J., Smith G.D., and Ebrahim S. Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study. BMJ 328 (2004) 831-836
16. Hart R.G., Tonarelli S.B., and Pearce L.A. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36 (2005) 1588-1593
17. Huber J., Stollberger C., Finsterer J., Schneider B., and Langer T. Quality of blood pressure control and risk of cerebral bleeding in patients with oral anticoagulation. Acta Med Austriaca 30 (2003) 6-9
18. Lip G.Y.H., Frison L., and Grind M. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 28 (2007) 752-759
19. Yamada M. Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci 226 (2004) 41-44
20. Smith E.E., and Eichler F. Cerebral amyloid angiopathy and lobar intracerebral hemorrhage. Arch Neurol 63 (2006) 148-151
21. Ng T.H., Leung S.Y., and Wong M.P. Cerebral amyloid angiopathy in Chinese: incidence and significance. Clin Neurol Neurosurg 93 (1991) 19-23
22. Ayala C., Greenlund K.J., Croft J.B., et al. Racial/ethnic disparities in mortality by stroke subtype in the United States, 1995-1998. Am J Epidemiol 154 (2001) 1057-1063
23. Klatsky A.L., Friedman G.D., Sidney S., Kipp H., Kubo A., and Armstrong M.A. Risk of hemorrhagic stroke in Asian American ethnic groups. Neuroepidemiology 25 (2005) 26-31